US$ 20.42
semaglutide prefilled syringe Why Patients Should Be Cautious About Clinics Distributing Syringes Therapeutic - ⚠️Safety advisory -
Description
Not for use during pregnancy or nursing without guidance from your provider
GLP-1 receptor agonists semaglutide and tirzepatide are associated with reduced risks of dementia, stroke, and mortality in adults with type 2 diabetes and obesity, new data show.
Longitudinal Targeted Minimum Loss-based Estimation, a method that adjusts for both baseline and time-varying confounding, was used to estimate absolute risks of cardiovascular outcomes under sustained use of GLP1-RA and DPP 4i (active comparator), adjusting for baseline and time-varying confounding

A total of 166 participants completed the trial

Prime the pen: Hold the pen with the needle pointing upwards and gently tap the cartridge to remove any air bubbles
